Skip to main content
L&C BIO Co., Ltd logo

L&C BIO Co., Ltd — Investor Relations & Filings

Ticker · 290650 ISIN · KR7290650001 KO Manufacturing
Open in API
Filings indexed 378 across all filing types
Latest filing 2022-03-11 AGM Information
Country KR South Korea
Listing KO 290650

About L&C BIO Co., Ltd

http://www.lncbio.co.kr/?locale=en_US

L&C BIO Co., Ltd. is a biotechnology company specializing in regenerative medicine. The company develops, manufactures, and commercializes human tissue-based medical devices and allograft treatment materials. Its core operations include the processing, storage, and distribution of human tissues, with a focus on skin, musculoskeletal, and soft tissues, utilizing patented processing technologies. The company's product portfolio also extends to other medical devices and cosmetics. L&C BIO supports its activities through dedicated research and development centers and manufacturing facilities, including a human tissue plant and a pharmaceutical plant, to advance its pipeline and serve global markets.

Recent filings

Filing Released Lang Actions
주주총회소집공고
AGM Information Classification · 98% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for L&C Bio. It contains the meeting agenda, details on voting procedures (including electronic voting), and management reference materials (경영참고사항) such as director activity reports and business overviews. This type of document is standard for providing shareholders with the necessary information to vote on board appointments, financial statements, and other corporate matters, which falls under the Proxy Solicitation & Information Statement category.
2022-03-11 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea (Proxy Solicitation Statement). It contains information regarding the upcoming Annual General Meeting (AGM), including the date, agenda items, and instructions for shareholders to exercise their voting rights via electronic proxy or in-person attendance. While it includes financial statements (as required by the proxy solicitation regulations), the primary purpose of the document is to solicit proxies for the AGM, making it a Proxy Solicitation & Information Statement.
2022-03-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically marked as a '정정신고' (Correction Report). It details changes to previously granted stock options, including adjustments to the number of recipients and the total number of shares granted due to resignations. This type of disclosure regarding changes to equity-based compensation and capital structure falls under the category of regulatory filings for corporate actions.
2022-03-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a '정정신고' (Correction Report) regarding a previous filing. It details the modification of stock option grants, including changes to the number of recipients and the total number of shares granted due to employee resignation. This type of disclosure regarding stock-based compensation and capital structure changes falls under the category of Regulatory Filings (RNS) as it is a specific corporate announcement to the financial authorities (Financial Services Commission/Korea Exchange) that does not fit into the more specific categories like 'Director's Dealing' or 'Share Issue'.
2022-03-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and includes a '정정신고' (Correction Report) header. It details the granting of stock options to specific employees and executives, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding stock-based compensation and capital structure changes falls under the category of regulatory filings related to share-based incentives, which is best classified as a Regulatory Filing (RNS) in the absence of a more specific 'Stock Option' category.
2022-03-11 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and includes a '정정신고' (Correction Report) header. It details the granting of stock options to specific employees, including the number of shares, exercise price, and valuation methodology. This type of disclosure regarding stock option grants and capital-related changes falls under the category of share-related regulatory filings.
2022-03-11 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.